Atellica Ch Enzymatic Hemoglobin A1c (a1c_e) Assay

Recall Summary Siemens Healthineers is recalling the Atellica CH Enzymatic Hemoglobin A1c assay across Canada due to a device performance issue. This is a laboratory test used to measure blood sugar control in patients with diabetes. The recall affects medical facilities and laboratories that use this testing system.

Product

Atellica CH Enzymatic Hemoglobin A1c (A1c_E) assay

Reason

Device performance issue

Classification

Class II

Category

medical device recall

Country

Canada

Agency

HC-DEVICES

Recall date

2026-06-18

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DEVICES

Recall details on Nibble Recalls: https://trynibble.app/recalls/c03d1104-0469-4c79-9d44-efc647c62b1e